Select Medical Q4 revenue +7.8% to $1.31B, adjusted EPS +50%; issues 2025 outlook

SELECT MEDICAL HOLDINGS CORP

2024-FY EPS reported $1.66 revenue$5,187,105,000

Q4 revenue $1.31B (+7.8% YoY); loss from continuing ops $10.5M vs profit $30.3M (impacted by $45.9M stock comp acceleration and $17.9M debt retirement loss).
Adjusted EPS from continuing ops $0.18 (+50% YoY); full-year adjusted EPS $0.94 (+74.1%).
Rehabilitation hospital segment Q4 margin declined to 21.2% from 25.5%; outpatient rehab full-year margin down to 8.7% from 9.4%.
Completed tax-free distribution of Concentra; no longer owns any shares.
2025 outlook: revenue $5.4-5.6B, Adj EBITDA $520-540M, diluted EPS $1.09-1.19.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.